Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
Category: Departments Finance
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
Prescription drug costs, abortion rights, and the future of Obamacare are key issues in the upcoming presidential election between Vice…
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid era
If the Covid era marked a boom time for digital health companies, 2024 was the reckoning. In a year that…
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
In this article, CVS Health, UnitedHealth Group, and Cigna are requesting Federal Trade Commission Chair Lina Khan and two other…
UnitedHealthcare CEO Brian Thompson fatally shot in targeted attack, gunman still at large
In this article, Brian Thompson, the CEO of UnitedHealth Group’s insurance unit, was fatally shot outside the Hilton hotel in…
NYPD releases 2 new photos of man sought in killing of UnitedHealthcare CEO
In this article, the New York Police Department has released two new photos of a person being sought in the…
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales disappointed
In this article, Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro reported weaker-than-expected sales for the third…
Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial
In this article, Eli Lilly announced on Wednesday that its obesity drug Zepbound resulted in more weight loss compared to…